At PsychoGenics, we understand the complexities disease research foundations encounter in their pursuit of developing treatments. Our decades-long partnerships with many disease research foundations have equipped us with a deep understanding of the unique challenges associated with disease-specific discovery. 

With our extensive expertise, we will help you evaluate and/or validate the best rodent disease models and identify translational endpoints to assess promising treatments. 

Our Foundation Partners

Unleash the Full Potential of Your Research 

Accelerate your discovery programs with our cutting-edge approach to research, including our AI-driven drug discovery platforms and analytical tools. Our extensive capabilities, customized solutions, and studies are designed to address the specific goals of your discovery programs. 

PsychoGenics researchers’ broad expertise spans diverse testing approaches, with a focus on optimal study design and data interpretation. Our specialty lies in identifying statistically relevant phenotypic changes in rodent disease models and tractable endpoints to enhance the reproducibility and translatability to the clinic. 

Your industry and academic drug discovery partners know they can trust a rodent model phenotype when PsychoGenics has done the characterization. 

Partner with us and transform your program


Get Started